Remedium Capital Partners, LLC
Remedium Capital Partners, LLC reported 6 holdings worth US$452M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 7, 2026
Remedium Capital Partners, LLC reported 6 holdings worth US$452M as of Jun 30, 2026. Largest: Oruka Therapeutics, Inc., Spyre Therapeutics, Inc. and Apogee Therapeutics, Inc. Filed Aug 7, 2026 (Form 13F).
- Holdings
- 6
- Value as reported
- US$452M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Oruka Therapeutics, Inc. | 1.57M | US$149M | 33.0% |
| Spyre Therapeutics, Inc. | 1.46M | US$130M | 28.8% |
| Apogee Therapeutics, Inc. | 587K | US$77.9M | 17.2% |
| Damora Therapeutics, Inc. | 2.05M | US$53.2M | 11.8% |
| Jade Biosciences, Inc. | 1.58M | US$35.1M | 7.8% |
| Crescent Biopharma, Inc. | 361K | US$6.5M | 1.4% |